Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Tivumecirnon

Product Specifications

UNSPSC Description

Tivumecirnon (FLX475) is an orally bioactive, selective CCR4 antagonist. Tivumecirnon can block the recruitment of immunosuppressive regulatory T cells (Treg) into the tumor microenvironment, leading to enhanced antitumor activity. Tivumecirnon has antitumor activity on EBV+ NK/T cell lymphoma and non-small cell lung cancer (NSCLC) combined with Pembrolizumab (HY-P9902). Tivumecirnon is promising for research of broad range of tumor types[1][2][3][4].

Target Antigen

CCR

Type

Reference compound

Related Pathways

GPCR/G Protein;Immunology/Inflammation

Applications

Cancer-programmed cell death

Field of Research

Cancer; Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/tivumecirnon.html

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

C[C@H](C1=C(C=C(C=C1)Cl)Cl)N2C3=NC(N4CC([C@H]5CCCN(C5)CCO)C4)=CN=C3C(C(F)(F)F)=N2

Molecular Weight

543.41

References & Citations

[1]Hilary Plake BECK, et al. Chemokine receptor modulators and uses thereof. WO2018022992.|[2]Adam Grant, et al. Abstract 2485: A combined mregDC and Treg signature associates with antitumor efficacy of CCR4 antagonist tivumecirnon FLX475. Cancer Res 15 March 2024; 84 (6_Supplement): 2485.|[3]Tae Min Kim, et al. 629-C Phase 2 safety and efficacy of oral CCR4 antagonist FLX475 (tivumecirnon) plus pembrolizumab in subjects with non-small cell lung cancer not previously treated with checkpoint inhibitor[J]. 2023.|[4]Dirk G. Brockstedt, et al., Clinical and biological activity of FLX475, an oral CCR4 antagonist, in advanced cancer. Journal of Clinical Oncology. 2023. 41, 2625-2625.

Shipping Conditions

Room Temperature

Product Datasheet

http://file.medchemexpress.com/batch_PDF/HY-148494/Tivumecirnon-DataSheet-MedChemExpress.pdf

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-148494/Tivumecirnon-SDS-MedChemExpress.pdf

Clinical Information

Phase 2

CAS Number

2174938-78-2

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

SEC14L5 Protein Vector (Human) (pPM-C-HA)
43290021 500 ng

SEC14L5 Protein Vector (Human) (pPM-C-HA)

Ask
View Details
CCR2 Antibody: RPE
MBS8000263-01 0.1 mg

CCR2 Antibody: RPE

Ask
View Details
CCR2 Antibody: RPE
MBS8000263-02 5x 0.1 mg

CCR2 Antibody: RPE

Ask
View Details
Shd rabbit pAb
ES6864-01 50 µL

Shd rabbit pAb

Ask
View Details
Shd rabbit pAb
ES6864-02 100 µL

Shd rabbit pAb

Ask
View Details
Anti-GLIPR1 Antibody
A08471 0.1 mg

Anti-GLIPR1 Antibody

Ask
View Details